Type of Cancer
Lung
Site
East Brunswick, Freehold, Somerville, Sparta
Sponsor
Genentech
Protocol Number
GO29436
Staging
4
Phase of Trial
3
Protocol Title
A Phase 3, Open-Label, Randomized Study Of Mpdl3280a (Anti-Pd-L1 Antibody) In Combination With Carboplatin + Paclitaxel With Or Without Bevacizumab Compared With Carboplatin + Paclitaxel + Bevacizumab In Chemotherapy Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer.
To Learn More Call
201-510-0910